Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Abstract

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...

Keywords

Renin–angiotensin systemAldosteroneCoronavirus disease 2019 (COVID-19)Internal medicineMedicinePeptidyl-Dipeptidase AAngiotensin-converting enzyme 2Angiotensin-converting enzymePharmacologyEndocrinologyBlood pressureDisease

MeSH Terms

Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme 2Angiotensin-Converting Enzyme InhibitorsBetacoronavirusCOVID-19Coronavirus InfectionsDown-RegulationHumansHypertensionPandemicsPeptidyl-Dipeptidase APneumoniaViralRenal InsufficiencyChronicRenin-Angiotensin SystemSARS-CoV-2

Affiliated Institutions

Related Publications

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario , Jewell A. Jessup , Mark C. Chappell +5 more

Background— Angiotensin-converting enzyme 2 (ACE2) has emerged as a novel regulator of cardiac function and arterial pressure by converting angiotensin II (Ang II) into the vaso...

2005 Circulation 1598 citations

Local Potentiation of Bradykinin-Induced Vasodilation by Converting-Enzyme Inhibition in Isolated Coronary Arteries

Wolfgang Auch–Schwelk , C. Bossaller , Matthias Claus +3 more

The interaction of angiotensin-converting enzyme (ACE) inhibitors and bradykinin was investigated in isolated bovine and human coronary arteries. Rings with and without endothel...

1992 Journal of Cardiovascular Pharmacology 33 citations

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

M R Law , Joan K. Morris , Nicholas Wald

With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in pre...

2009 BMJ 2727 citations

Captopril Treatment of Chronic Heart Failure in the Very Old

Veerle De Bock , Tony Mets , Marco Romagnoli +1 more

The study gives further evidence that angiotensin-converting enzyme inhibitor treatment for very old patients with chronic heart failure is useful.

1994 Journal of Gerontology 24 citations

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan , Yuanyuan Zhang , Yaning Li +3 more

How SARS-CoV-2 binds to human cells Scientists are racing to learn the secrets of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), which is the cause of the pandemi...

2020 Science 5508 citations

Publication Info

Year: 2020
Type: article
Volume: 382
Issue: 17
Pages: 1653-1659
Citations: 2138
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2138

OpenAlex

Influential

1662

CrossRef

Cite This

APA Style

                            
                                
                                    Muthiah Vaduganathan, 
                                
                                    Orly Vardeny, 
                                
                                    Thomas Michel
                                
                                et al.
                            
                            (2020). 
                            Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. 
                            New England Journal of Medicine
                            , 382
                            (17)
                            , 1653-1659.
                            https://doi.org/10.1056/nejmsr2005760
                        

Identifiers

DOI: 10.1056/nejmsr2005760
PMID: 32227760
PMCID: PMC7121452

Data Quality

Data completeness: 86%